Hinge Health’s CEO is sizing up a giant market opportunity for digital healthcare
It’s been less than a year since digital physical therapy startup Hinge Health went public last May. But…
Hospitals Fighting Measles Confront a Challenge: Few Doctors Have Seen It Before
ASHEVILLE, N.C. — At around 2 a.m., 7-year-old twin brothers arrived at Mission Hospital in Asheville. Both had…
ARPA-H-funded PROSPR program focuses on the biological hallmarks of aging
Columbia University Mailman School of Public Health has received an award as part of the PROactive Solutions for Prolonging Resilience (PROSPR) program within the Advanced…
Klothea initiates longevity-focused human trial of klotho therapy
Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…
‘A confident answer isn’t the same as a correct one’ — I asked medical experts whether you should use ChatGPT for health advice, and I was shocked by their answers
People are increasingly turning to ChatGPT and other AI tools for health advice. They’re using them to make…
This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income
Pfizer (NYSE: PFE) is one of the world’s largest and most respected pharmaceutical companies. That is an important…
UiPath’s Healthcare AI Push Tests Long Term Growth Story
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access
New, lower list price of $675 per month across Wegovy®, Ozempic®, and Rybelsus®, effective January 1, 2027, addresses…
Half of Britons avoid calling GP when they are ill, survey finds | Health
Almost half the public delay or avoid contacting their GP surgery when they are ill, mainly because they…
Survey Reveals AI Is Delivering Clear Return on Investment in Healthcare
AI is accelerating every aspect of healthcare — from radiology and drug discovery to medical device manufacturing and…
What’s next for Novo Nordisk’s obesity drug CagriSema
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
Oura Launches Proprietary AI Model Built Specifically for Women’s Health
Image: Oura Oura has announced its first proprietary large language model designed specifically for women’s health – a…